Ocular Therapeutix OCUL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$88.61M-37.1% | -$64.65M+6.9% | -$69.42M-2.4% | -$67.81M-5.9% | -$64.05M-32.4% | ||
| $1.28M+2.9% | $1.25M+16.7% | $1.07M+4.2% | $1.03M+4.6% | $981K+3.2% | ||
| $15.58M+37.2% | $11.36M-2.8% | $11.69M+20.8% | $9.68M-7.4% | $10.46M+45.3% | ||
| -$65.99M-21.6% | -$54.25M-6.9% | -$50.73M+8.2% | -$55.24M-23.7% | -$44.67M-13.3% | ||
| $4.66M+64.2% | $2.84M-52.6% | $5.99M+381% | $1.25M-35.6% | $1.93M+857% | ||
| -$4.66M-64.2% | -$2.84M+52.6% | -$5.99M-437% | -$1.12M+42.3% | -$1.93M-857% | ||
| $294K-99.9% | $449.38M+4,239% | $10.36M-89.4% | $97.81M+2,238% | $4.18M-7.3% | ||
| -$70.36M-118% | $392.29M+946% | -$46.36M-212% | $41.45M+198% | -$42.42M— | ||
| -$70.66M-23.8% | -$57.09M-0.7% | -$56.72M-0.4% | -$56.48M-21.2% | -$46.6M-17.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ocular Therapeutix generate?
- Ocular Therapeutix (OCUL) generated -$226.2M in operating cash flow over the trailing twelve months.
- What is Ocular Therapeutix's free cash flow?
- After $14.7M of capital expenditures, Ocular Therapeutix's free cash flow was -$240.9M over the trailing twelve months, down 62.3% year over year.
- Where does Ocular Therapeutix's cash flow data come from?
- Every line is extracted from Ocular Therapeutix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
